InsidersTradesSigma
Track the ST百灵 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, ST百灵 has published 1 public disclosures. Market capitalisation: €6.4bn. The latest transaction was filed on 7 June 2021 (Sale). Among the most active insiders: 姜伟. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€36m
1 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,135 of 29,024 companies
33.6
score / 100
Value37
Quality30
FCF yld9.8%
Earn yld-1.6%
EV/EBITDA45.1x
ROE-3.1%
Gross mgn47%
Net mgn-3.4%
Debt/EBITDA7.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 June 2021
About ST百灵
ST百灵 is a company in the health and pharmaceutical sector, listed on the XSHE market. It specializes in the development and manufacturing of pharmaceutical products.